BioSpace News Archive

Business

Affimed Stock More Than Doubles After $4.9 Billion Deal with Roche

Heidelberg, Germany-based Affimed NV inked a licensing deal with Switzerland-based Roche for $96 million upfront, but that was only a fraction of the entire deal. Affimed shares rocketed, more than doubling to hit $148.07.

August 28, 2018
·
2 min read
·
Mark Terry
FDA

FDA Approves Shire’s Takhzyro for Hereditary Angioedema

The U.S. Food and Drug Administration (FDA) approved Shire’s Takhzyro (lanadelumab-flyo) injection to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older. The drug was accepted while under priority review.

August 28, 2018
·
2 min read
·
Mark Terry
Business

Editas Medicine CMO Plans to Leave the Company at the End of 2018

Cambridge, Mass.-based Editas Medicine, one of the leading CRISPR gene editing companies, is losing its chief medical officer. Gerald Cox will step down from his role at the end of the year.

August 28, 2018
·
2 min read
·
Alex Keown
Drug Development

Poxel Announces Completion of Patient Enrollment for the TIMES 3 Trial in the Phase 3 Registration Program for Imeglimin, an Investigational Therapeutic Agent for Type 2 Diabetes, in Japan

Phase 3 TIMES data readout is on track for 2019

August 28, 2018
·
6 min read
Beactica Closes Financing Round to Accelerate its Pipeline of Novel Cancer Therapeutics

Beactica today announced the completion of its latest financing round, providing significant funds that will be used to advance the Company’s internal pipeline of discovery-stage oncology programmes.

August 28, 2018
·
1 min read
NeuroVive’s NVP015 Program Will be Accelerated Through Award of Major Research Grant to Children’s Hospital of Philadelphia

NeuroVive Pharmaceutical AB today announced that scientists at the company’s research partner the Children’s Hospital of Philadelphia (CHOP) have received a three-year grant (W81XWH-17-PRMRP-TTDA), in total of $4,090,281 USD, from the U.S. Department of Defense

August 28, 2018
·
5 min read
Business

Horizon Discovery announces collaboration with major pharmaceutical company on single cell RNAseq-linked CRISPR screening

Co-development and implementation of a new CRISPR-based screening technology platform to address critical gaps in target ID and validation

August 28, 2018
·
3 min read
Business

Congenica Appoints Wendy Britten as Chief Financial Officer

Congenica, the global provider of clinical genomics interpretation software, today announced the appointment of Mrs Wendy Britten as its new Chief Financial Officer (CFO), effective 1st September, 2018.

August 28, 2018
·
2 min read
Business

Electronic Cigarette Use May Reverse the Harm Resulting From Tobacco Smoking in COPD Patients, Even in the Long Term

A new study that was recently published in the International Journal of Chronic Obstructive Pulmonary Disease, led by Riccardo Polosa, MD, PhD suggests that electronic cigarette (EC) use may reverse some of the harm resulting from tobacco smoking in patients with chronic obstructive pulmonary disease (COPD).

August 28, 2018
·
4 min read
Genetown

Insulet to Present at Upcoming September 2018 Investor Conferences

Insulet Corporation today announced that management will present at two upcoming investor conferences in New York City, New York:

August 28, 2018
·
2 min read